4172.T
The company operates in the software industry, specializing in health care technology solutions, and generates revenue primarily through the sale and licensing of its software products and services.
Business. The company operates in the software industry, specializing in health care technology solutions, and generates revenue primarily through the sale and licensing of its software products and services.
At a glance
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-06-25 · SE
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-07-08 · AU
- Rate decisionBank of Canada rate decision (press conf.)2026-07-15 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-07-16 · EU
- Rate decisionBank of Japan rate decision (press conf.)2026-07-16 · JP
- Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the software industry, specializing in health care technology solutions, and generates revenue primarily through the sale and licensing of its software products and services.
The company maintains a strong liquidity position, with a current ratio of 5.24, indicating a robust ability to meet short-term obligations. It has no long-term debt and holds significant cash and equivalents of ¥1.5 billion, contributing to its low liquidity risk. The company's return on equity of 10.68% and return on assets of 9.49% suggest efficient use of equity and assets to generate profit, outperforming the typical performance metrics for the software industry.
The company's profitability is evident from its operating income of ¥541.2 million and net income of ¥448.1 million, which reflect a healthy gross margin of 77% (¥1.85 billion gross profit on ¥2.41 billion revenue). These figures indicate a strong competitive position and effective cost management, aligning with the industry's preferred metrics for profitability and returns.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, suggesting a potential concentration risk. This lack of diversification could expose the company to regional economic downturns or regulatory changes affecting its primary market.
Looking ahead, the company is expected to maintain its growth trajectory, with a positive outlook for the current fiscal year and the next. The absence of dilution risk and the company's strong cash position support this outlook. The company's free cash flow of ¥266.8 million and operating cash flow of ¥461.2 million indicate a solid financial foundation for future investments and shareholder returns.
The company's risk assessment indicates a low probability of dilution and no immediate filing-based liquidity or dilution flags, suggesting a stable capital structure. The company's financial health is further supported by its strong equity base of ¥4.2 billion and minimal liabilities of ¥525.9 million.
Recent events and filings have not indicated any significant changes in the company's operations or financial strategy. The company's consistent performance and lack of dilution risk suggest a stable and predictable business model. The company's financial statements and disclosures reflect a transparent and well-managed business.
- The company has a strong liquidity position with a current ratio of 5.24 and no long-term debt.
- It demonstrates high profitability with a return on equity of 10.68% and a return on assets of 9.49%.
- The company's revenue is concentrated in a single segment, which may pose a concentration risk.
- The company is expected to maintain its growth trajectory with a positive outlook for the current and next fiscal years.
- The company has a low probability of dilution and no immediate liquidity or dilution flags.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Forward curve
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 4172.T Market data — financials · 2026-05-26